<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref110">
 <mixed-citation publication-type="journal" id="cit110">
  <name>
   <surname>Glupczynski</surname>
   <given-names>Y.</given-names>
  </name>; 
  <name>
   <surname>Lagast</surname>
   <given-names>H.</given-names>
  </name>; 
  <name>
   <surname>Van Der Auwera</surname>
   <given-names>P.</given-names>
  </name>; 
  <name>
   <surname>Thys</surname>
   <given-names>J.</given-names>
  </name>; 
  <name>
   <surname>Crokaert</surname>
   <given-names>F.</given-names>
  </name>; 
  <name>
   <surname>Yourassowsky</surname>
   <given-names>E.</given-names>
  </name>; 
  <name>
   <surname>Meunier-Carpentier</surname>
   <given-names>F.</given-names>
  </name>; 
  <name>
   <surname>Klastersky</surname>
   <given-names>J.</given-names>
  </name>; 
  <name>
   <surname>Kains</surname>
   <given-names>J. P.</given-names>
  </name>; 
  <name>
   <surname>Serruys-Schoutens</surname>
   <given-names>E.</given-names>
  </name>
  <article-title>Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria</article-title>. 
  <source>Antimicrob. Agents Chemother.</source>
  <year>1986</year>, 
  <volume>29</volume>, 
  <fpage>52</fpage>â€“
  <lpage>57</lpage>. 
  <pub-id pub-id-type="doi">10.1128/AAC.29.1.52</pub-id>.
  <pub-id pub-id-type="pmid">2942100</pub-id>
 </mixed-citation>
</ref>
